Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 110 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $496.66 | 23 | $0 (2024) |
| ITI, Inc. | $303.01 | 13 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $295.79 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $277.76 | 17 | $0 (2024) |
| Lundbeck LLC | $211.10 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $191.89 | 5 | $0 (2024) |
| Axsome Therapeutics, Inc. | $103.46 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $100.28 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $80.14 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $64.25 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,110 | 59 | Teva Pharmaceuticals USA, Inc. ($249.51) |
| 2023 | $526.02 | 23 | ITI, Inc. ($208.77) |
| 2022 | $621.37 | 25 | Teva Pharmaceuticals USA, Inc. ($179.03) |
| 2021 | $57.84 | 3 | ITI, Inc. ($34.10) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/10/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ADHD | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ADHD | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $40.31 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: ADHD | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 36 | $7,200 | $1,832 |
| 2022 | 2 | 31 | 77 | $17,750 | $4,918 |
| 2021 | 1 | 15 | 42 | $8,400 | $2,238 |
| 2020 | 1 | 12 | 46 | $9,200 | $1,596 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 36 | $7,200 | $1,832 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 47 | $11,750 | $3,315 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 30 | $6,000 | $1,603 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 42 | $8,400 | $2,238 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 46 | $9,200 | $1,596 | 17.3% |
About Racheal Aneke
Racheal Aneke is a Psychiatric/Mental Health healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2019. The National Provider Identifier (NPI) number assigned to this provider is 1073071684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Racheal Aneke has received a total of $2,315 in payments from pharmaceutical and medical device companies, with $1,110 received in 2024. These payments were reported across 110 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Aneke has provided services to 69 Medicare beneficiaries, totaling 201 services with total Medicare billing of $10,584. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Riverside, CA
- Active Since 03/04/2019
- Last Updated 01/22/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1073071684
Products in Payments
- REXULTI (Drug) $397.91
- CAPLYTA (Drug) $383.15
- INGREZZA (Drug) $295.79
- INVEGA SUSTENNA (Drug) $191.89
- AUSTEDO (Drug) $179.03
- Austedo XR (Drug) $174.09
- UZEDY (Drug) $143.54
- Auvelity (Drug) $103.46
- COBENFY (Drug) $81.67
- ABILIFY ASIMTUFII (Drug) $73.82
- LOREEV XR (Drug) $56.23
- HETLIOZ (Drug) $47.09
- TRINTELLIX (Drug) $46.57
- Azstarys (Drug) $34.88
- Dyanavel XR (Drug) $33.22
- Xelstrym (Drug) $19.86
- FANAPT (Drug) $17.16
- ABILIFY MAINTENA (Drug) $17.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Riverside
Mr. Samuel Kaufman, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $17,573
Quiana Cooper, Np, NP
Psychiatric/Mental Health — Payments: $4,889
Ms. Britni Turano, Ms Rn Pmhnp-Bc, MS RN PMHNP-BC
Psychiatric/Mental Health — Payments: $4,799
Deep Patel
Psychiatric/Mental Health — Payments: $4,551
Mr. Sukh Dev Singh Khalsa, P.m.h.n.p, P.M.H.N.P
Psychiatric/Mental Health — Payments: $3,033
Jessica Millan, Np, NP
Psychiatric/Mental Health — Payments: $2,235